Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Ovarian cancer is an aggressive disease, with a 10-year survival rate of 35%.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.